Stem Cells International

Copyright © 2016 Jūratė Savickienė et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. Perin, S. Sedrakyan, S. Da Sacco, and R. De Filippo, “Characterization of human amniotic fluid stem cells and their pluripotential capability,” Methods in Cell Biology, vol. 86, pp. 85–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
2. Q. You, L. Cai, J. Zheng, X. Tong, D. Zhang, and Y. Zhang, “Isolation of human mesenchymal stem cells from third-trimester amniotic fluid,” International Journal of Gynecology & Obstetrics, vol. 103, no. 2, pp. 149–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
3. P. Dekoninck, J. Toelen, S. Zia et al., “Routine isolation and expansion late mid trimester amniotic fluid derived mesenchymal stem cells in a cohort of fetuses with congenital diaphragmatic hernia,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 178, pp. 157–162, 2014. View at Publisher · View at Google Scholar · View at Scopus
4. N. Siegel, M. Rosner, M. Hanneder, A. Valli, and M. Hengstschläger, “Stem cells in amniotic fluid as new tools to study human genetic diseases,” Stem Cell Reviews, vol. 3, no. 4, pp. 256–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
5. S. Da Sacco, R. E. De Filippo, and L. Perin, “Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration,” Current Opinion in Organ Transplantation, vol. 16, no. 1, pp. 101–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
6. O. Trohatou, N. P. Anagnou, and M. G. Roubelakis, “Human amniotic fluid stem cells as an attractive tool for clinical applications,” Current Stem Cell Research and Therapy, vol. 8, no. 2, pp. 125–132, 2013. View at Publisher · View at Google Scholar · View at Scopus
7. P. De Coppi, G. Bartsch Jr., M. M. Siddiqui et al., “Isolation of amniotic stem cell lines with potential for therapy,” Nature Biotechnology, vol. 25, no. 1, pp. 100–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
8. M. Di Trapani, G. Bassi, E. Fontana et al., “Immune regulatory properties of ${\text{CD117}}^{\text{pos}}$ amniotic fluid stem cells vary according to gestational age,” Stem Cells and Development, vol. 24, no. 1, pp. 132–143, 2015. View at Publisher · View at Google Scholar · View at Scopus
9. M. M. Bonab, K. Alimoghaddam, F. Talebian, S. H. Ghaffari, A. Ghavamzadeh, and B. Nikbin, “Aging of mesenchymal stem cell in vitro,” BMC Cell Biology, vol. 7, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
10. J. Campisi and F. D. di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
11. W. Wagner, P. Horn, M. Castoldi et al., “Replicative senescence of mesenchymal stem cells: a continuous and organized process,” PLoS ONE, vol. 3, no. 5, p. e2213, 2008. View at Google Scholar
12. L. Hayflick, “The limited in vitro lifetime of human diploid cell strains,” Experimental Cell Research, vol. 37, no. 3, pp. 614–636, 1965. View at Publisher · View at Google Scholar · View at Scopus
13. W. Wagner, S. Bork, P. Horn et al., “Aging and replicative senescence have related effects on human stem and progenitor cells,” PLoS ONE, vol. 4, no. 6, Article ID e5846, 2009. View at Publisher · View at Google Scholar · View at Scopus
14. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
15. R. Izadpanah, C. Trygg, B. Patel et al., “Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue,” Journal of Cellular Biochemistry, vol. 99, no. 5, pp. 1285–1297, 2006. View at Publisher · View at Google Scholar · View at Scopus
16. W.-Q. Chen, N. Siegel, L. Li, A. Pollak, M. Hengstschläger, and G. Lubec, “Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5–25,” Journal of Proteome Research, vol. 8, no. 11, pp. 5285–5295, 2009. View at Publisher · View at Google Scholar · View at Scopus
17. A. Madeira, C. L. da Silva, F. dos Santos, E. Camafeita, J. M. S. Cabral, and I. Sá-Correia, “Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-de-based quantitative proteomics,” PLoS ONE, vol. 7, no. 8, Article ID e43523, 2012. View at Publisher · View at Google Scholar · View at Scopus
18. V. Janzen, R. Forkert, H. E. Fleming et al., “Stem-cell ageing modified by the cyclin-dependent kinase inhibitor $\text{p}{\text{16}}^{\text{INK4a}}$,” Nature, vol. 443, no. 7110, pp. 421–426, 2006. View at Publisher · View at Google Scholar · View at Scopus
19. T. Kiyono, S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz, “Both Rb/$\text{p}{\text{16}}^{\text{INK4a}}$ inactivation and telomerase activity are required to immortalize human epithelial cells,” Nature, vol. 396, no. 6706, pp. 84–88, 1998. View at Publisher · View at Google Scholar
20. C. J. Sherr and F. McCormick, “The RB and p53 pathways in cancer,” Cancer Cell, vol. 2, no. 2, pp. 103–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
21. J. Gil and G. Peters, “Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all,” Nature Reviews Molecular Cell Biology, vol. 7, no. 9, pp. 667–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
22. J. Nichols, B. Zevnik, K. Anastassiadis et al., “Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4,” Cell, vol. 95, no. 3, pp. 379–391, 1998. View at Publisher · View at Google Scholar · View at Scopus
23. C.-C. Tsai, P.-F. Su, Y.-F. Huang, T.-L. Yew, and S.-C. Hung, “Oct4 and nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells,” Molecular Cell, vol. 47, no. 2, pp. 169–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
24. A. Schellenberg, Q. Lin, H. Schüler et al., “Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks,” Aging, vol. 3, no. 9, pp. 873–888, 2011. View at Publisher · View at Google Scholar · View at Scopus
25. A. Noer, L. C. Lindeman, and P. Collas, “Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells,” Stem Cells and Development, vol. 18, no. 5, pp. 725–736, 2009. View at Publisher · View at Google Scholar · View at Scopus
26. J.-W. Jung, S. Lee, M.-S. Seo et al., “Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3,” Cellular and Molecular Life Sciences, vol. 67, no. 7, pp. 1165–1176, 2010. View at Publisher · View at Google Scholar · View at Scopus
27. A.-Y. So, J.-W. Jung, S. Lee, H.-S. Kim, and K.-S. Kang, “DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs,” PLoS ONE, vol. 6, no. 5, Article ID e19503, 2011. View at Publisher · View at Google Scholar · View at Scopus
28. J. Savickiene, G. Treigyte, S. Baronaite et al., “Human amniotic fluid mesenchymal stem cells from second- and third-trimester amniocentesis: differentiation potential, molecular signature, and proteome analysis,” Stem Cells International, vol. 2015, Article ID 319238, 15 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
29. W. Wagner, A. D. Ho, and M. Zenke, “Different facets of aging in human mesenchymal stem cells,” Tissue Engineering Part B: Reviews, vol. 16, no. 4, pp. 445–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
30. J. Ren, D. F. Stroncek, Y. Zhao et al., “Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence,” Stem Cell Research, vol. 11, no. 3, pp. 1060–1073, 2013. View at Publisher · View at Google Scholar · View at Scopus
31. D. C. Colter, R. Class, C. M. DiGirolamo, and D. J. Prockop, “Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3213–3218, 2000. View at Publisher · View at Google Scholar · View at Scopus
32. C. T. Maguire, B. L. Demarest, J. T. Hill et al., “Genome-wide analysis reveals the unique stem cell identity of human amniocytes,” PLoS ONE, vol. 8, no. 1, Article ID e53372, 2013. View at Publisher · View at Google Scholar · View at Scopus
33. W. H. Persutte and R. R. Lenke, “Failure of amniotic-fluid-cell growth: is it related to fetal aneuploidy?” The Lancet, vol. 345, no. 8942, pp. 96–97, 1995. View at Publisher · View at Google Scholar · View at Scopus
34. D. Moschidou, K. Drews, A. Eddaoudi, J. Adjaye, P. de Coppi, and P. V. Guillot, “Molecular signature of human amniotic fluid stem cells during fetal development,” Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 73–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
35. H. Cheng, L. Qiu, J. Ma et al., “Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts,” Molecular Biology Reports, vol. 38, no. 8, pp. 5161–5168, 2011. View at Publisher · View at Google Scholar · View at Scopus
36. K. R. Shibata, T. Aoyama, Y. Shima et al., “Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion,” Stem Cells, vol. 25, no. 9, pp. 2371–2382, 2007. View at Publisher · View at Google Scholar · View at Scopus
37. J. Kim, J. W. Kang, J. H. Park et al., “Biological characterization of long-term cultured human mesenchymal stem cells,” Archives of Pharmacal Research, vol. 32, no. 1, pp. 117–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
38. I. Ben-Porath and R. A. Weinberg, “The signals and pathways activating cellular senescence,” The International Journal of Biochemistry & Cell Biology, vol. 37, no. 5, pp. 961–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. M. Serrano, A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe, “Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a,” Cell, vol. 88, no. 5, pp. 593–602, 1997. View at Publisher · View at Google Scholar · View at Scopus
40. K. Webley, J. A. Bond, C. J. Jones et al., “Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage,” Molecular and Cellular Biology, vol. 20, no. 8, pp. 2803–2808, 2000. View at Publisher · View at Google Scholar · View at Scopus
41. F. di Fagagna, P. M. Reaper, L. Clay-Farrace et al., “A DNA damage checkpoint response in telomere-initiated senescence,” Nature, vol. 426, no. 6963, pp. 194–198, 2003. View at Publisher · View at Google Scholar
42. N. Dyson, “The regulation of E2F by pRB-family proteins,” Genes & Development, vol. 12, no. 15, pp. 2245–2262, 1998. View at Publisher · View at Google Scholar · View at Scopus
43. E. Hara, R. Smith, D. Parry, H. Tahara, S. Stone, and G. Peters, “Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 859–867, 1996. View at Publisher · View at Google Scholar · View at Scopus
44. D. S. Peeper, T. M. Upton, M. H. Ladha et al., “Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein,” Nature, vol. 386, no. 6621, pp. 177–181, 1997. View at Publisher · View at Google Scholar · View at Scopus
45. G. H. Stein, L. F. Drullinger, A. Soulard, and V. Dulić, “Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts,” Molecular and Cellular Biology, vol. 19, no. 3, pp. 2109–2117, 1999. View at Publisher · View at Google Scholar · View at Scopus
46. R. Margueron, G. Li, K. Sarma et al., “Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms,” Molecular Cell, vol. 32, no. 4, pp. 503–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
47. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
48. M. Hackl, S. Brunner, K. Fortschegger et al., “miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging,” Aging Cell, vol. 9, no. 2, pp. 291–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
49. L. He, J. M. Thomson, M. T. Hemann et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005. View at Publisher · View at Google Scholar · View at Scopus
50. J. Grillari, M. Hackl, and R. Grillari-Voglauer, “miR-17-92 cluster: ups and downs in cancer and aging,” Biogerontology, vol. 11, no. 4, pp. 501–506, 2010. View at Publisher · View at Google Scholar · View at Scopus
51. K. Woods, J. M. Thomson, and S. M. Hammond, “Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors,” The Journal of Biological Chemistry, vol. 282, no. 4, pp. 2130–2134, 2007. View at Publisher · View at Google Scholar · View at Scopus
52. H.-L. Yan, G. Xue, Q. Mei et al., “Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis,” The EMBO Journal, vol. 28, no. 18, pp. 2719–2732, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. A. M. Krichevsky and G. Gabriely, “miR-21: a small multi-faceted RNA,” Journal of Cellular and Molecular Medicine, vol. 13, no. 1, pp. 39–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
54. O. Trohatou, D. Zagoura, V. Bitsika et al., “Sox2 suppression by miR-21 governs human mesenchymal stem cell properties,” Stem Cells Translational Medicine, vol. 3, no. 1, pp. 54–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
55. Q. Gan, T. Yoshida, O. G. McDonald, and G. K. Owens, “Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells,” Stem Cells, vol. 25, no. 1, pp. 2–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
56. M. Narita, S. Nũnez, E. Heard et al., “Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence,” Cell, vol. 113, no. 6, pp. 703–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
57. S. Hänzelmann, F. Beier, E. G. Gusmao et al., “Replicative senescence is associated with nuclear reorganization and with dna methylation at specific transcription factor binding sites,” Clinical Epigenetics, vol. 7, article 19, 2015. View at Publisher · View at Google Scholar · View at Scopus
58. W. Zhang, J. Li, K. Suzuki et al., “A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging,” Science, vol. 348, no. 6239, pp. 1160–1163, 2015. View at Publisher · View at Google Scholar · View at Scopus
59. D. Willis-Martinez, H. W. Richards, N. A. Timchenko, and E. E. Medrano, “Role of HDAC1 in senescence, aging, and cancer,” Experimental Gerontology, vol. 45, no. 4, pp. 279–285, 2010. View at Publisher · View at Google Scholar · View at Scopus